title: Gut microbiota and hepatic encephalopathy.
abstract: There is a strong relationship between liver and gut; while the portal venous system receives blood from the gut, and its contents may affect liver functions, liver in turn, affects intestinal functions through bile secretion. There is robust evidence that the pathogenesis of hepatic encephalopathy (HE) is linked to alterations in gut microbiota and their by-products such as ammonia, indoles, oxindoles, endotoxins, etc. In the setting of intestinal barrier and immune dysfunction, these by-products are involved in the pathogenesis of complications of liver cirrhosis including HE and systemic inflammation plays an important role. Prebiotics, probiotics and synbiotics may exhibit efficacy in the treatment of HE by modulating the gut flora. They improve derangement in flora by decreasing the counts of pathogenic bacteria and thus improving the endotoxemia, HE and the liver disease. Current evidence suggest that the trials evaluating the role of probiotics in the treatment of HE are of not high quality and all trials had high risk of bias and high risk of random errors. Therefore, the use of probiotics for patients with HE cannot be currently recommended. Further RCTs are required. This review summarizes the main literature findings about the relationships between gut flora and HE, both in terms of the pathogenesis and the treatment of HE.
authors: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. rkpsdhiman@hotmail.com
authors: Radha K
authors: RK
authors: Dhiman
mesh_terms: D000641:Ammonia / Q000378:metabolism; D000818:Animals; D006501:Hepatic Encephalopathy / Q000378:metabolism / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D007422:Intestines / Q000382:microbiology*; D064307:Microbiota / Q000502:physiology*; D019936:Probiotics
chemical_list: D000641:Ammonia